Alphinity Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361M Buy
+301,331
New +$308M 6.02% 5
2022
Q2
Sell
-37,302
Closed -$10.7M 33
2022
Q1
$10.7M Sell
37,302
-7,216
-16% -$1.86M 0.25% 22
2021
Q4
$12.3M Buy
44,518
+11,750
+36% +$2.98M 0.28% 24
2021
Q3
$7.57M Sell
32,768
-22,298
-40% -$5.5M 0.28% 24
2021
Q2
$12.6M Sell
55,066
-403,659
-88% -$81.1M 0.48% 22
2021
Q1
$85.7M Buy
458,725
+131,359
+40% +$25.7M 4% 17
2020
Q4
$55.3M Buy
327,366
+67,068
+26% +$10M 4.64% 9
2020
Q3
$38.5M Buy
+260,298
New +$40.3M 3.75% 18

Other funds holding LLY

Alphinity Investment Management's LLY Position: Q2 2026 in Review

Alphinity Investment Management opened a new position in Eli Lilly (LLY) in Q2 2026: 301,331 shares worth $361M. The stake represents 6.02% of the portfolio and ranks #5 among its holdings. This is a return to the name: Alphinity Investment Management previously reported a position in LLY as recently as Q1 2022.

Alphinity Investment Management first reported a position in LLY in Q3 2020 and has held it in 8 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alphinity Investment Management held 301,331 shares of Eli Lilly worth $361M as of Q2 2026.
  • Eli Lilly was a new Alphinity Investment Management position in Q2 2026.
  • Eli Lilly made up 6.02% of Alphinity Investment Management's portfolio in Q2 2026, its #5 holding.
  • Alphinity Investment Management first reported a position in Eli Lilly in Q3 2020 and has held it in 8 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alphinity Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.